HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of endotoxin-induced vascular hyporeactivity by 4-amino-tetrahydrobiopterin.

Abstract
The 4-amino analogue of tetrahydrobiopterin (4-ABH(4)) is a potent pterin-site inhibitor of nitric oxide synthases (NOS). Although 4-ABH(4) does not exhibit selectivity between purified NOS isoforms, a pronounced selectivity of the drug towards inducible NOS (iNOS) is apparent in intact cells. This work was carried out to investigate the potential iNOS selectivity of 4-ABH(4) in isolated pig pulmonary and coronary arteries. Endothelium-dependent relaxations of pig pulmonary and coronary artery strips to bradykinin or calcium ionophore A23187 were inhibited by 4-ABH(4) in a concentration-dependent manner. Half-maximal inhibition was observed at 60 - 65 microM (pulmonary artery) and 200 - 250 microM 4-ABH(4) (coronary artery). Pig coronary artery strips precontracted with 0.1 microM 9, 11-dideoxy-9, 11-methanoepoxy-prosta-glandin F(2alpha) (U46619) showed a time-dependent relaxation (monitored for up to 18 h) upon incubation with 1 microg ml(-1) lipopolysaccharide (LPS). Addition of 10 microM 4-ABH(4) 1 h after LPS led to a pronounced inhibition of the LPS-triggered relaxation, whereas the pterin antagonist had no effect when given> or =4 h after LPS. Incubation of pulmonary and coronary artery strips with 1 microg ml(-1) LPS attenuated contractile responses to norepinephrine (1 microM) and U46619 (0.1 microM). This hyporeactivity of the blood vessels to vasoconstrictor agents was inhibited by 4-ABH(4) in a concentration-dependent manner [IC(50)=17.5+/-5.9 microM (pulmonary artery) and 20.7+/-3 microM (coronary artery)]. The effect of 0.1 mM 4-ABH(4) was antagonized by coincubation with 0.1 mM sepiapterin, which is known to supply intracellular BH(4) via a salvage pathway. These results demonstrate that 4-ABH(4) is a fairly selective inhibitor of iNOS in an in vitro model of endotoxaemia, suggesting that this drug and/or related pterin-site NOS inhibitors may be useful to increase blood pressure in severe infections associated with a loss of vascular responsiveness to constrictor agents caused by endotoxin-triggered iNOS induction in the vasculature.
AuthorsH D Gibraeil, P Dittrich, S Saleh, B Mayer
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 131 Issue 8 Pg. 1757-65 (Dec 2000) ISSN: 0007-1188 [Print] England
PMID11139456 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Endotoxins
  • Enzyme Inhibitors
  • Hydrazines
  • Lipopolysaccharides
  • Nitric Oxide Donors
  • Nitrogen Oxides
  • Pteridines
  • Pterins
  • Vasoconstrictor Agents
  • 4-amino-tetrahydrobiopterin
  • Nitroarginine
  • Biopterin
  • Calcimycin
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • 1,1-diethyl-2-hydroxy-2-nitrosohydrazine
  • sepiapterin
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • sapropterin
  • Bradykinin
  • Norepinephrine
Topics
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid (pharmacology)
  • Animals
  • Biopterin (analogs & derivatives, metabolism, pharmacology)
  • Bradykinin (pharmacology)
  • Calcimycin (pharmacology)
  • Coronary Vessels (drug effects, physiology)
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular (physiology)
  • Endotoxins (pharmacology)
  • Enzyme Inhibitors (pharmacology)
  • Hydrazines (pharmacology)
  • In Vitro Techniques
  • Lipopolysaccharides (pharmacology)
  • Nitric Oxide Donors (pharmacology)
  • Nitric Oxide Synthase (antagonists & inhibitors, metabolism)
  • Nitric Oxide Synthase Type II
  • Nitroarginine (pharmacology)
  • Nitrogen Oxides
  • Norepinephrine (pharmacology)
  • Pteridines (pharmacology)
  • Pterins
  • Pulmonary Artery (drug effects, physiology)
  • Swine
  • Vasoconstriction (drug effects)
  • Vasoconstrictor Agents (pharmacology)
  • Vasodilation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: